Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Clinical trial NCT04703192 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04703192
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2023-05-10
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.